Efficacy and Safety Trial of ADU-S100 and Pembrolizumab in Head and Neck Cancer
A phase 2 trial of ADU-S100 in Head and neck squamous cell carcinoma, run by Chinook Therapeutics, Inc. (formerly Aduro), recorded as terminated on the registry.
Overview
Efficacy and Safety Trial of ADU-S100 and Pembrolizumab in Head and Neck Cancer is a phase 2 interventional study registered as NCT03937141 by Chinook Therapeutics, Inc. (formerly Aduro), with 16 participants recorded, started 2019-08-26 and due to reach its primary completion in 2021-05-10. Interventions recorded: ADU-S100. Conditions recorded: Metastatic Head and Neck Cancer, Recurrent Head and Neck Cancer.
Linked to the drug ADU-S100 because the registry names it among its interventions and Head and neck squamous cell carcinoma among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialMIT-001 for Prevention of CCRT-Induced OM in HNSCC Patients
Shares Head and neck squamous cell carcinoma and the tag pipeline.
- TrialA Study of DM005 in Patients With Advanced Solid Tumors
Shares Head and neck squamous cell carcinoma and the tag pipeline.
- TrialA Phase I/IIa Clinical Trial to Investigate BVAC-E6E7 in Subjects With HPV Positive HNSCC.
Shares Head and neck squamous cell carcinoma and the tag pipeline.
- TrialIntratumoral N17350 in Advanced Solid Tumors
Shares Head and neck squamous cell carcinoma and the tag pipeline.
- TrialResponse Adaptive Radiotherapy Following Immunotherapy-based Induction for Non-HPV Related HNSCC
Shares Head and neck squamous cell carcinoma and the tag pipeline.
- TrialFID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell Carcinoma
Shares Head and neck squamous cell carcinoma and the tag pipeline.
- TrialBGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer
Shares Head and neck squamous cell carcinoma and the tag pipeline.
- TrialIparomlimab and Tuvonralimab Plus Hypofractionated Radiotherapy and Chemotherapy for HAHNSCC
Shares Head and neck squamous cell carcinoma and the tag pipeline.